Dr Raymond Oppong

Dr Raymond Oppong

Department of Applied Health Sciences
Associate Professor in Health Economics

Contact details

Address
Health Economics
Institute of Applied Health Research
Occupational Health Building
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK
Dr Raymond Oppong is an Associate Professor in Health Economics at the Health Economics Unit, University of Birmingham. 

He is the Programme Lead for the MSc in Health Economics and Health Policy and MSc in Health Economics and Econometrics.

Raymond's work spans a range of vital areas within health economics. His main interests include economic evaluations, particularly in the context of antimicrobial resistance and musculoskeletal diseases. Additionally, his contributions extend to global health and economic analysis conducted alongside multinational, cluster, and factorial trials.

Raymond's impact is well-documented through his numerous publications in renowned journals, including The Lancet, British Journal of General Practice, The European Journal of Health Economics, Journal of Antimicrobial Chemotherapy, and Rheumatology. His research findings have reached diverse audiences across Europe, Africa and Asia. Raymond is committed to fostering health economics capacity in Low- and Middle-Income countries, further exemplifying his dedication to advancing the field globally.

Qualifications

  • PhD in Health Economics. University of Birmingham 2017
  • MSc Health Economics and Health Policy University of Birmingham 2006
  • BA (Hons) Economics and Geography Kwame Nkrumah University of Science and Technology 2003

Biography

Before joining the Health Economics Unit, Raymond Oppong qualified with a BA (Hons) in Economics and Geography (first class) from the Kwame Nkrumah University of Science and Technology Ghana. He went on to work as a teaching assistant at the Department of Economics, KNUST Kumasi, Ghana. 

In 2006, Raymond obtained an MSc in Health Economics and Health Policy from the University of Birmingham. He has since worked as a Research Fellow and Lecturer at the Health Economics Unit. 

Raymond currently works in collaboration with the Arthritis Research UK Primary Care Centre at Keele University on a number of trial based and modelling studies within musculoskeletal disease. 

Teaching

  • Health Economics and Health Policy MSc/Diploma
  • Public Health MPH/Diploma/Certificate

Research

Raymond’s main research relates to economic evaluations alongside various types of trials such as factorial trials, cluster randomised trials and multinational trials. His most recent research has been related to musculoskeletal disease, where he has been assessing various interventions/programmes for the treatment and management of musculoskeletal disease. Output related to this has been presented at conferences such as the British Society of Rheumatology conference and published in journals such as The Lancet. 

He is also actively involved in research related to the economics of antibiotic resistance and has had the experience of working on the EU funded Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE) project where he took a lead role in designing the health economics aspects of the study. He is currently working on methods for incorporating the cost of antibiotic resistance in economic evaluations. Output from his work on antibiotic resistance has been published in the Journal of Antimicrobial Chemotherapy and British Journal of General Practice and also presented at international conferences such as EuHEA.

Raymond is also interested in methodological work around the economic analysis of different trial designs. For example, his PhD focused on methods for the analysis of multinational trials and he has also been able to develop some methodological work related to the analysis of factorial trials. Output from his work in this area has been published in Rheumatology and PLoS ONE and presented at conferences such as HESG.

Raymond currently coordinates the Research Design Service (RDS) activities in the health economics unit at the University of Birmingham. This team engages in providing advice on the design of economic components of research projects submitted for funding to national competitions. He is actively involved in putting together grant applications and has been a successful co-applicant on a number of grants submitted to the NIHR HTA and NIHR RfPB.

Publications

Recent publications

Article

Williams, EV, Goranitis, I, Oppong, R, Perry, SJ, Devall, AJ, Martin, JT, Mammoliti, K-M, Beeson, LE, Sindhu, KN, Galadanci, H, Al-beity, FA, Qureshi, Z, Hofmeyr, GJ, Moran, N, Fawcus, S, Mandondo, S, Middleton, L, Hemming, K, Oladapo, OT, Gallos, ID, Coomarasamy, A & Roberts, TE 2024, 'A cost-effectiveness analysis of early detection and bundled treatment of postpartum haemorrhage alongside the E-MOTIVE trial', Nature Medicine. https://doi.org/10.1038/s41591-024-03069-5

National Institute for Health and Care Research (NIHR) Global Health Research Unit on Global Surgery 2024, 'Global access to technologies to support safe and effective inguinal hernia surgery: prospective, international cohort study', British Journal of Surgery, vol. 111, no. 7, znae164. https://doi.org/10.1093/bjs/znae164

NIHR Global Health Research Unit on Global Surgery 2024, 'Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): A model-based cost-effectiveness analysis of a pragmatic, cluster-randomised trial in seven low-income and middle-income countries', Lancet Global Health, vol. 12, no. 2, pp. e235-e242. https://doi.org/10.1016/S2214-109X(23)00538-7

AMR-X Collaborators 2024, 'System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework', The Lancet. Microbe. https://doi.org/10.1016/S2666-5247(24)00003-X

NIHR Global Health Research Unit on Global Surgery 2023, 'A Prospective, Observational Cost Comparison of Laparoscopic and Open Appendicectomy in Three Tertiary Hospitals in Nigeria', World journal of surgery. https://doi.org/10.1007/s00268-023-07148-5

Oppong, R, Lewis, M, Campbell, P, Dunn, KM, Foster, N, Hill, J & Jowett, S 2023, 'Comparison of healthcare utilisation, costs and health related quality of life across the subgroups defined by the Keele STarT MSK Tool', Rheumatology, vol. 62, no. 6, pp. 2076–2082. https://doi.org/10.1093/rheumatology/keac560

Holden, M, Hawarden, A, Paskins, Z, Roddy, E, Mallen, CD, Liddle, J, Bourton, A, Jinks, C, HIT trial team, Bromley, K, Lewis, M, Kigozi, J & Oppong, R 2023, 'Experiences of living with hip osteoarthritis and of receiving advice, education and ultrasound-guided intra-articular hip injection in the hip injection trial: A qualitative study', Musculoskeletal care. https://doi.org/10.1002/msc.1830

Maes, D, McMullan, C, Ford, S, Wilson, R, Oppong, R & Aiyegbusi, OL 2023, 'Experiences of patients and their relatives of postoperative radiological surveillance and surveillance intensity following primary resection of a soft tissue sarcoma and its impact on their quality of life: a systematic review protocol', BMJ open, vol. 13, no. 5, e070327. https://doi.org/10.1136/bmjopen-2022-070327

Kachapila, M, Monahan, M, Ademuyiwa, AO, Adinoyi, YM, Biccard, BM, George, C, Ghosh, DN, Glasbey, J, Morton, D, Osayomwanbo, O, Pearse, R, Roberts, T, Suroy, A, Yakubu, SY & Oppong, R 2023, 'Exploring the cost-effectiveness of high versus low perioperative fraction of inspired oxygen in the prevention of surgical site infections among abdominal surgery patients in three low-and middle-income countries', BJA Open, vol. 7, 100207. https://doi.org/10.1016/j.bjao.2023.100207

Kachapila, M, Kigozi, J & Oppong, R 2023, 'Exploring the roles of players in strategic purchasing for healthcare in Africa – A scoping review', Health Policy and Planning, vol. 38, no. 1, pp. 97-108. https://doi.org/10.1093/heapol/czac093

Kachapila, M, Sindhu, S, Dhiman, J, Ghosh, D, John, S, Monahan, M, Morton, D, Roberts, T, Suroy, A & Oppong, R 2023, 'The cost of paediatric abdominal tuberculosis treatment in India: evidence from a teaching hospital', Experimental Results, vol. 4, e18. https://doi.org/10.1017/exp.2023.16

Burton, C, Rathod-Mistry, T, Blackburn, S, Blagojevic-Bucknall, M, Chesterton, LS, Davenport, G, Dziedzic, K, Higginbottom , A, Jowett, S, Myers, H, Oppong, R, van der Windt, D, Hay, E & Roddy, E 2023, 'The effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of a randomised trial', Rheumatology, vol. 62, no. 2, keac219. https://doi.org/10.1093/rheumatology/keac219

Brettell, E, Högler, W, Woolley, R, Cummins, C, Mathers, J, Oppong, R, Roy, L, Khan, A, Hunt, C & Dattani, M 2023, 'The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD: a non-inferiority Randomised Controlled Trial (RCT)', Trials, vol. 24, no. 1, 548. https://doi.org/10.1186/s13063-023-07562-z

CROCODILE study group & Paul, J 2022, 'Catastrophic expenditure and treatment attrition in patients seeking comprehensive colorectal cancer treatment in India: A prospective multicentre study', The Lancet Regional Health - Southeast Asia, vol. 6, 100058. https://doi.org/10.1016/j.lansea.2022.100058

Review article

Kachapila, M, Watson, S, Pinkney, T, Hall, JA, Andronis, L & Oppong, R 2024, 'Economic considerations in designs and modifications of multi-arm, multi-stage adaptive, and adaptive-platform randomised control trials: A systematic literature review', Value in Health. https://doi.org/10.1016/j.jval.2024.10.3849

View all publications in research portal